Skip to Main Content

Paper Details

Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Circulation
4
2023
Author NameAffiliation
Mikhail KosiborodSaint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.).
James F LutherUniversity of Pittsburgh
Michelle N GongAlbert Einstein College of Medicine
Pooja KhatriUniversity of Cincinnati Medical Center
Matthew D NealUniversity of Pittsburgh
  • 1 - 5

Datasets

Release 1.2